Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb 7;20(5):1228-37.
doi: 10.3748/wjg.v20.i5.1228.

Inflammatory bowel disease: an increased risk factor for neurologic complications

Affiliations
Review

Inflammatory bowel disease: an increased risk factor for neurologic complications

Germán Morís. World J Gastroenterol. .

Abstract

Only a very few systematic studies have investigated the frequency of neurologic disorders in patients with Crohn's disease (CD) and ulcerative colitis (UC), which are the two main types of inflammatory bowel disease (IBD). Results have been inconsistent and variable, owing to differences in case-finding methods and evaluated outcomes in different studies. The most frequent neurologic manifestations reported in CD and UC populations are cerebrovascular disease (with either arterial or venous events), demyelinating central nervous system disease, and peripheral neuropathy (whether axonal or demyelinating); however, the literature describes numerous nervous system disorders as being associated with IBD. The pathogenesis of nervous system tissue involvement in IBD has yet to be elucidated, although it seems to be related to immune mechanisms or prothrombotic states. The recently-introduced tumor necrosis factor (TNF) inhibitors have proven successful in controlling moderate to severe IBD activity. However, severe neurologic disorders associated with TNF inhibitors have been reported, which therefore raises concerns regarding the effect of anti-TNF-α antibodies on the nervous system. Although neurological involvement associated with IBD is rarely reported, gastroenterologists should be aware of the neurologic manifestations of IBD in order to provide early treatment, which is crucial for preventing major neurologic morbidity.

Keywords: Extraintestinal manifestations; Inflammatory bowel disease; Multiple sclerosis; Neuropathy; Stroke; Tumor necrosis factor inhibitor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sagittal magnetic resonance venography imaging scan showing thrombosis of the superior sagittal sinus in a 51-year-old man with cerebral venous thrombosis. He had been diagnosed with ulcerative colitis involving the ileum and colon 15 years before.
Figure 2
Figure 2
Sagittal (A) and axial (B) cranial magnetic resonance imaging scan depicting several hyperintense focal lesions in supratentorial white matter. The patient was a 45-year-old woman with relapsing-remitting multiple sclerosis and a 23-year history of ulcerative colitis.

References

    1. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–1640. - PubMed
    1. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365:1713–1725. - PubMed
    1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066–2078. - PMC - PubMed
    1. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380:1590–1605. - PubMed
    1. Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380:1606–1619. - PubMed

MeSH terms

Substances